Capricor Therapeutics (NasdaqCM:CAPR) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsAJ Bergmann - CFOLinda Marbán - CEOConference Call ParticipantsBoobalan Pachaiyappan - Managing Director and Senior Biotech AnalystCatherine Novack - Healthcare AnalystEdward Tenthoff - Managing Director and Senior Research AnalystJoe Pantginis - Managing Director and Senior Healthcare AnalystKristen Kluska - Managing Director and Biotechnology Equity Research AnalystLeland Gershell - Managing Director ...